Clinical trials: Brain Metastasases
NSCLC, Brain Metastasases
A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)
A multicenter, single-arm, open-label study evaluating the safety and efficacy of AK112 combined with chemotherapy as first-line treatment for non-squamous NSCLC patients with BRAIN metastases and negative driver genes
- Trial name
- NCT06684873
- Testing
- AK112 Injection
- Where
- China
- Volunteers
- 55 people
- Sponsor
- Sun Yat-sen University